Puklin, Leah S.
Irwin, Melinda L.
Sanft, Tara
Ferrucci, Leah M.
Harrigan, Maura
McGowan, Courtney
Cartmel, Brenda
Zupa, Michelle
Winer, Eric P.
Deyling, Maryann
Ligibel, Jennifer A.
Basen-Engquist, Karen
Spiegelman, Donna
Sharifi, Mona
Funding for this research was provided by:
National Cancer Institute (F31CA268894, R25CA203650, 5R01CA207753)
National Center for Advancing Translational Sciences (TR001864)
Breast Cancer Research Foundation
National Heart, Lung, and Blood Institute (R01HL151603)
National Institute on Minority Health and Health Disparities (R01MD014853)
Article History
Received: 10 May 2024
Accepted: 6 August 2024
First Online: 14 August 2024
Declarations
:
: The study was conducted according to the guidelines of Helsinki and approved by the Yale Human Investigation Committee (HIC #2000031514) and the Dana Farber Cancer Institute Human Investigation Committee (HIC #23–004).
: Verbal consent was obtained from all individual participants in the study.
: The authors declare no competing interests.